David Braun (@BraunMDPhD) / X

David Braun

1,551 posts

David Braun

@BraunMDPhD

Oncologist, physician-scientist @YaleCancer @YaleMed | cancer immunotherapy, genomics, kidney cancer | tweets ≠ medical advice. ASCO FCOI:bit.ly/3Sv8P6A

Yale, New Haven, CT

Joined April 2018

Pinned
David Braun
@BraunMDPhD
Jul 3, 2025
1/ Recently, our lab has worked with outstanding groups (#TeamScience) to address some key questions in kidney cancer immunobiology: Can we use machine-learning approaches to classify RCC and predict response? @Cancer_Cell What drives exceptional response with immunotherapies?
13K
David Braun
@BraunMDPhD
Jan 9, 2022
Officially settling in here @YaleCancer @YaleMed, and I am grateful for the warm welcome! If you are interested in cancer immunotherapy, translational research, genomics, or kidney cancer, please contact me ([email protected]). We are hiring at all levels (postgrad, MS, PhD)!
David Braun
@BraunMDPhD
Dec 9, 2021
An exciting but also a bit of a bittersweet announcement - after 8+ amazing years @BrighamMedRes @DanaFarber @harvardmed, I will be starting a new laboratory (thebraunlab.org) @YaleCancer @YaleMed on January 1, 2022 1/n
thebraunlab.org
BraunLab
David Braun
@BraunMDPhD
Mar 10, 2022
Out in @NEJM this week, our perspective on some recent outstanding work defining the phenotype of tumor-infiltrating T cells across cancer types, and our thoughts on next steps. Tumor-Infiltrating T Cells — A Portrait | NEJM nejm.org/doi/full/10.10… @YaleCancer @YaleMed
nejm.org
Tumor-Infiltrating T Cells — A Portrait | NEJM
Genetic landscaping and T cells are all the rage when it comes to tumor biology. Put them together and you get a comprehensive view of the T cell in the context of different types of cancer. The au...
David Braun
@BraunMDPhD
Mar 9, 2022
And the BraunLab is officially up and running! It may just be culturing some cell lines today, but feels good to be at the bench again. Thanks to my right hand man Nick Schindler and all of the support from @YaleCancer @YaleMed
David Braun
@BraunMDPhD
Mar 11, 2021
1/ Happy to share our latest work out today in @Cancer_Cell – a single-cell dissection of the kidney cancer immune microenvironment that uncovers important immune circuitry in advanced disease stages @DanaFarber @DanaFarberNews @harvardmed @broadinstitute
cell.com
Progressive immune dysfunction with advancing disease stage in renal cell carcinoma
The immune cell changes that occur with advancing disease stage in renal cell carcinoma are incompletely characterized. Braun et al. show that terminally exhausted CD8+ T cells and M2-like tumor-as...
David Braun
@BraunMDPhD
Oct 20, 2022
Great time chatting about cancer immunotherapy and the importance of physician-scientists with gold medalist @nathanwchen. Thanks for stopping by our lab! @YaleCancer @SmilowCancer @YaleMed
David Braun
@BraunMDPhD
May 29, 2020
1/ Excited to share our work on genomic & immune determinants of anti-PD1 response in RCC, presented today #ASCO20 and published @NatureMedicine. Thanks to patients; mentors/collaborators #CathyWu, @DrChoueiri, @shuklasachet, @LabSignoretti, @VanAllenLab nature.com/articles/s4159…
David Braun
@BraunMDPhD
Nov 5, 2021
A very nice overview of some of the differences between anti-CTLA-4 and anti-PD-1 therapies from Dr. Allison #IKCS2021
David Braun
@BraunMDPhD
Jul 19, 2023
Very grateful to @theNCI and @CDMRP for the support to better understand and treat kidney cancer. Importantly, we are hiring postdocs/research scientists with expertise in experimental immunology. If you have extensive experience in immunology, please contact me!
Yale Cancer Center
@YaleCancer
Jul 19, 2023
Congratulations to the lab of @BraunMDPhD! The team has received approximately $5.75M in funding from @theNCI and @DeptofDefense to investigate the immune microenvironment of renal cell carcinoma. #RCC #kidneycancer #cancerresearch @YaleMed @SmilowCancer yalecancercenter.org/news-article/n…
28K
David Braun
@BraunMDPhD
Jan 27, 2024
Historic moment form @DrChoueiri , first adjuvant OS benefit in kidney cancer #GU24
13K
David Braun
@BraunMDPhD
Feb 23, 2023
Thank you @YaleCancer @YaleMed and all my past and present mentors for the support!
Yale Cancer Center
@YaleCancer
Feb 23, 2023
Congratulations to @BraunMDPhD, who has been awarded an American Society for Clinical Investigation (@the_asci) Young Physician-Scientist Award. Dr. Braun will attend the AAP/ASCI/APSA Joint Meeting in April. @SmilowCancer @YaleMed @YNHH
19K
David Braun
@BraunMDPhD
Sep 15, 2022
Very grateful to @KidneyCancer for the award, and to the amazing team (@Chrislabaki1 @LisaHenske @shuklasachet @VanAllenLab @DrChoueiri and others) as we try to better understand and treat this histology and beyond @YaleCancer @SmilowCancer
Kidney Cancer
@KidneyCancer
Sep 15, 2022
Replying to @KidneyCancer
⭐️Congratulations to KCA Trailblazer Award winner @BraunMDPhD @YaleCancer @YaleMed! His research will dissect the #immunobiology of #chromophobe #RCC using single-cell transcriptomics. #kidneycancer kidneycancer.org/2022-grants/
David Braun
@BraunMDPhD
Sep 20, 2024
Thank you! I am very grateful, especially to receive anything in Dr. Wood's name. I will certainly do my best to try to honor his tremendous legacy @YaleCancer @YaleMed @Yale_Urology @yalepathology
Kidney Cancer
@KidneyCancer
Sep 20, 2024
🎉 Congratulations @BraunMDPhD recipient of the KCA’s Christopher G Wood Rising Star Award! Join us to celebrate at #IKCSNA24 Nov 7-9 in Louisville, KY! Early reg open through Oct 10: kidneycancer.org/ikcs/2024-ikcs…
8.6K